Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Cash Flows (Unaudited)

v3.22.0.1
Consolidated Statements Cash Flows (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (6,200,981) $ (5,877,240)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 3,212 3,081
Acquired in-process research and development 120,000
Amortization of operating lease right-of-use asset 22,235 19,719
Share-based compensation 332,075 370,055
Non-cash interest 316
Change in operating assets and liabilities:    
Prepaid expenses and other current assets 15,447 (63,132)
Accounts payable (1,669,012) 201,922
Accrued expenses (563,294) 382,836
Operating lease liability (22,232) (19,242)
Deferred income (129,799)
Net cash used in operating activities (8,092,349) (4,981,685)
Cash flows from investing activities:    
Purchase of in-process research and development (120,000)
Net cash used in investing activities (120,000)
Cash flows from financing activities:    
Proceeds from the exercise of warrants 2
Repayments of related-party notes (20,124)
Net cash used in financing activities (20,122)
Net decrease in cash (8,212,349) (5,001,807)
Cash, beginning of period 27,622,067 7,349,903
Cash, end of period $ 19,409,718 $ 2,348,096